 AUSTIN, Texas, July 28, 2021 GLOBE NEWSWIRE -- TFF Pharmaceuticals, Inc. NASDAQ: TFFP, a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing TFF technology platform, today announced that its President and CEO, Glenn Mattes, will be available for one-on-one meetings and will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Monday, August 9, 2021 at 2:00pm EST. 